Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines

Detalhes bibliográficos
Autor(a) principal: Pérez, O.
Data de Publicação: 2018
Outros Autores: Graham, S., Lastre, M., Ellis, C. D., Pupo, R. R., Tellez-Martínez, D. [UNESP], Batista-Duharte, A. [UNESP]
Tipo de documento: Artigo
Idioma: eng
spa
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.vacun.2018.09.003
http://hdl.handle.net/11449/188383
Resumo: Neisseria meningitidis outer membrane vesicles or proteoliposomes (PLs) have been used as vaccines and adjuvants. Despite the presence of potentially toxic amounts of lipopolysaccharide (LPS), they have been shown to be safe, well tolerated, and immunogenic. This suggests that LPS-PL may have reduced LPS toxicity. In this study, it is shown that the ability of PL to induce pro-inflammatory cytokine production in human U937 histiocytic cell line is significantly lower than that of an equivalent concentration of purified LPS. This demonstrates that certain components or physical properties of PL reduce the pro-inflammatory activity of their endogenous LPS. To investigate the mechanisms responsible for this protective effect, PLs were fractionated and an assessment was made of the ability of the resulting fractions to induce inflammatory cytokine expression. Several individual PLs fractions were more potent inducers of pro-inflammatory cytokine production than the non-fractionated PLs. The majority of the pro-inflammatory activities appeared to be mediated by the presence of LPS in the fractions, as shown by the ability of an anti-CD14 antibody to block it. However, in two PL fractions, the production of IL-8, and to a lesser extent IL-6, was not inhibited by anti-CD14 treatment, indicating that pro-inflammatory components other than LPS could also be present in PL. Eight proteins present in the fractions were identified by n-terminal sequencing. The results of this study suggest that two of them, PorB, and in particular, the RmpM protein, may also contribute to the pro-inflammatory activity of N. meningitidis PL. These results could support the development of PLs as vaccine adjuvant.
id UNSP_73d7c9b98fcd918c359c9730f412a743
oai_identifier_str oai:repositorio.unesp.br:11449/188383
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccinesLos lipopolisacáridos de Neisseria meningitidis serogrupo B inducen un reducido efecto proinflamatorio dentro del proteoliposoma usado en vacunas cubanas antimeningocócicasAdjuvantLPSNeisseria meningitidisPro-inflammatory cytokinesProteoliposomeNeisseria meningitidis outer membrane vesicles or proteoliposomes (PLs) have been used as vaccines and adjuvants. Despite the presence of potentially toxic amounts of lipopolysaccharide (LPS), they have been shown to be safe, well tolerated, and immunogenic. This suggests that LPS-PL may have reduced LPS toxicity. In this study, it is shown that the ability of PL to induce pro-inflammatory cytokine production in human U937 histiocytic cell line is significantly lower than that of an equivalent concentration of purified LPS. This demonstrates that certain components or physical properties of PL reduce the pro-inflammatory activity of their endogenous LPS. To investigate the mechanisms responsible for this protective effect, PLs were fractionated and an assessment was made of the ability of the resulting fractions to induce inflammatory cytokine expression. Several individual PLs fractions were more potent inducers of pro-inflammatory cytokine production than the non-fractionated PLs. The majority of the pro-inflammatory activities appeared to be mediated by the presence of LPS in the fractions, as shown by the ability of an anti-CD14 antibody to block it. However, in two PL fractions, the production of IL-8, and to a lesser extent IL-6, was not inhibited by anti-CD14 treatment, indicating that pro-inflammatory components other than LPS could also be present in PL. Eight proteins present in the fractions were identified by n-terminal sequencing. The results of this study suggest that two of them, PorB, and in particular, the RmpM protein, may also contribute to the pro-inflammatory activity of N. meningitidis PL. These results could support the development of PLs as vaccine adjuvant.Royal SocietyDepartment of Immunology University of Medical ScienceDepartment of Microbiology and Immunology University of Newcastle upon Tyne The Medical School, Framlington PlaceUniversity of Sheffield D Floor School of Medicine and Biomedical Sciences, Beech Hill RoadSão Paulo State University (UNESP) School of Pharmaceutical Sciences Department of Clinical AnalysisSão Paulo State University (UNESP) School of Pharmaceutical Sciences Department of Clinical AnalysisUniversity of Medical ScienceThe Medical SchoolSchool of Medicine and Biomedical SciencesUniversidade Estadual Paulista (Unesp)Pérez, O.Graham, S.Lastre, M.Ellis, C. D.Pupo, R. R.Tellez-Martínez, D. [UNESP]Batista-Duharte, A. [UNESP]2019-10-06T16:06:19Z2019-10-06T16:06:19Z2018-07-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article52-60http://dx.doi.org/10.1016/j.vacun.2018.09.003Vacunas, v. 19, n. 2, p. 52-60, 2018.1578-88571576-9887http://hdl.handle.net/11449/18838310.1016/j.vacun.2018.09.0032-s2.0-85056800881Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengspaVacunasinfo:eu-repo/semantics/openAccess2024-06-21T15:18:13Zoai:repositorio.unesp.br:11449/188383Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T14:06:07.839860Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
Los lipopolisacáridos de Neisseria meningitidis serogrupo B inducen un reducido efecto proinflamatorio dentro del proteoliposoma usado en vacunas cubanas antimeningocócicas
title Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
spellingShingle Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
Pérez, O.
Adjuvant
LPS
Neisseria meningitidis
Pro-inflammatory cytokines
Proteoliposome
title_short Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
title_full Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
title_fullStr Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
title_full_unstemmed Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
title_sort Neisseria meningitidis serogroup B lipopolysaccharides induce a lower pro-inflammatory effect within the proteoliposome used in Cuban anti-meningococcal vaccines
author Pérez, O.
author_facet Pérez, O.
Graham, S.
Lastre, M.
Ellis, C. D.
Pupo, R. R.
Tellez-Martínez, D. [UNESP]
Batista-Duharte, A. [UNESP]
author_role author
author2 Graham, S.
Lastre, M.
Ellis, C. D.
Pupo, R. R.
Tellez-Martínez, D. [UNESP]
Batista-Duharte, A. [UNESP]
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv University of Medical Science
The Medical School
School of Medicine and Biomedical Sciences
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Pérez, O.
Graham, S.
Lastre, M.
Ellis, C. D.
Pupo, R. R.
Tellez-Martínez, D. [UNESP]
Batista-Duharte, A. [UNESP]
dc.subject.por.fl_str_mv Adjuvant
LPS
Neisseria meningitidis
Pro-inflammatory cytokines
Proteoliposome
topic Adjuvant
LPS
Neisseria meningitidis
Pro-inflammatory cytokines
Proteoliposome
description Neisseria meningitidis outer membrane vesicles or proteoliposomes (PLs) have been used as vaccines and adjuvants. Despite the presence of potentially toxic amounts of lipopolysaccharide (LPS), they have been shown to be safe, well tolerated, and immunogenic. This suggests that LPS-PL may have reduced LPS toxicity. In this study, it is shown that the ability of PL to induce pro-inflammatory cytokine production in human U937 histiocytic cell line is significantly lower than that of an equivalent concentration of purified LPS. This demonstrates that certain components or physical properties of PL reduce the pro-inflammatory activity of their endogenous LPS. To investigate the mechanisms responsible for this protective effect, PLs were fractionated and an assessment was made of the ability of the resulting fractions to induce inflammatory cytokine expression. Several individual PLs fractions were more potent inducers of pro-inflammatory cytokine production than the non-fractionated PLs. The majority of the pro-inflammatory activities appeared to be mediated by the presence of LPS in the fractions, as shown by the ability of an anti-CD14 antibody to block it. However, in two PL fractions, the production of IL-8, and to a lesser extent IL-6, was not inhibited by anti-CD14 treatment, indicating that pro-inflammatory components other than LPS could also be present in PL. Eight proteins present in the fractions were identified by n-terminal sequencing. The results of this study suggest that two of them, PorB, and in particular, the RmpM protein, may also contribute to the pro-inflammatory activity of N. meningitidis PL. These results could support the development of PLs as vaccine adjuvant.
publishDate 2018
dc.date.none.fl_str_mv 2018-07-01
2019-10-06T16:06:19Z
2019-10-06T16:06:19Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.vacun.2018.09.003
Vacunas, v. 19, n. 2, p. 52-60, 2018.
1578-8857
1576-9887
http://hdl.handle.net/11449/188383
10.1016/j.vacun.2018.09.003
2-s2.0-85056800881
url http://dx.doi.org/10.1016/j.vacun.2018.09.003
http://hdl.handle.net/11449/188383
identifier_str_mv Vacunas, v. 19, n. 2, p. 52-60, 2018.
1578-8857
1576-9887
10.1016/j.vacun.2018.09.003
2-s2.0-85056800881
dc.language.iso.fl_str_mv eng
spa
language eng
spa
dc.relation.none.fl_str_mv Vacunas
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 52-60
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128316139372544